Alvotech is trading 5.37% up at ISK 510.00, with no clear company-specific announcement identified to explain the move.
- The live price context is for August 14, 2026.
- Alvotech is scheduled to report first-half 2026 results on August 19.
- FDA inspection and biosimilar-resubmission news occurred earlier; broader U.S. markets are mostly flat, with no strong macro catalyst confirmed.